When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform. Insilico leads a pack of companies using AI to rapidly come up with drug ideas humans might never think…
The startup world celebrates bold personalities and fast pitches, yet many of the most thoughtful innovations come from quiet thinkers who question assumptions and look deeper..
The new model, called π0.7, represents what the company describes as an early but meaningful step toward the long-sought goal of a general-purpose robot brain.
AI is accelerating work across every department, but without alignment and clear standards, most companies are scaling inefficiencies instead of real progress.